Gyldendal ASA (GYL)
Oslo Stock Exchange · Norway · prices in NOK · close of 23 Oct 2026
Key indicators
| Last close | NOK 424.00 |
|---|---|
| 52-week range | 400.00 – 500.00 |
| Return, 1 month / 3 months | +3.9% / +1.0% |
| Return, 1 year / 3 years | +0.3% / −13.8% |
| Trend | Below its 200-day average |
| RSI (14) | 46 |
| Volatility (1 year) | 44.4% |
| Worst drawdown (1 year) | -18.0% |
| Average daily value traded | 0.01M NOK |
| Dividend yield | 1.9% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Gyldendal ASA is a Norwegian publishing group based in Oslo. It publishes fiction and non-fiction books, textbooks and educational materials, and children's literature through its imprints, serving general readers, schools and other institutions in Norway. The company also has interests in book retailing and related publishing activities, and its catalogue spans Norwegian and translated literature alongside learning resources for the classroom.
On this site Gyldendal ASA appears as a stock on the Oslo Stock Exchange (Norway), code GYL, with prices in Norwegian kroner (NOK). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Gyldendal ASA (GYL) trades on the Oslo Stock Exchange in Norway. It last closed at NOK 424.00 on 23 October 2026.
Its price-based Market X-Ray is 42 out of 100 (a weak price profile), ranking 194 of 294 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 0.3% and over the last three months it rose 1.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Oslo Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 52 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -2.3% | ||
| From 52-week high | -13.1% | ||
| Momentum | 51 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 1.0% | ||
| 6-month return | 0.4% | ||
| 12-month return, skipping the last month | -3.4% | ||
| Stability (higher is calmer) | 56 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 44.4% | ||
| Worst drawdown, 1 year (smaller is calmer) | -18.0% | ||
| Liquidity | 1 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.01M NOK | ||
| Zero-volume days | 33.3% | ||
| Income | 22 · Weak | Dividend is small or irregular. | |
| Dividend yield | 1.9% | ||
| Years with dividends | 4 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
- Income: Dividend is small or irregular.
Returns
| 1 week | +0.0% |
|---|---|
| 1 month | +3.9% |
| 3 months | +1.0% |
| 6 months | +0.3% |
| 1 year | +0.3% |
| 3 years | −13.8% |
| 5 years | −21.2% |
Signals
| 50-day / 200-day average | 432.76 / 433.94 |
|---|---|
| Golden / death cross (60 days) | Death, 4 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 5.72 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 19 Jun 2026 | NOK 8.0000 |
| 18 Jun 2025 | NOK 3.5000 |
| 28 Jun 2023 | NOK 7.0000 |
| 8 Jun 2022 | NOK 10.0000 |
| 4 Jun 2021 | NOK 10.0000 |
| 26 Jun 2020 | NOK 7.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Oslo Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.